NSE filing, NSE: JUBLCPL. Summary written from the filing by ALFA Finder's alert engine.
Jubilant Agri and Consumer Products Ltd: key numbers
- Share price
- ₹1,915.60
- Market cap
- ₹2,903 Cr
- Revenue (annual)
- ₹1,857 Cr
- Net profit (annual)
- ₹127.6 Cr
- P/E (TTM)
- 28.7×Sector 28.6×
- Promoter holding
- 74.36%+0.00% QoQ
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Agri and Consumer Products Ltd
All →Jubilant Agri and Consumer Products Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹5,921 Mn (+15% YoY), but EBITDA ₹284 Mn (−56%, 4.8% margin) and PAT ₹176 Mn (−58%). Performance Polymers & Chemicals sales +33%; Agri weak.
Jubilant Agri and Consumer Products Q2 FY27 Results: Net Profit ₹17.6 Cr, Down 58.4% YoY
Jubilant Agri and Consumer Products approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The standalone P&L shows quarterly revenue from operations of ₹58,769 lakhs and net profit of ₹1,712 lakhs.
- Key figure
- Net profit ₹17.6 Cr · -58.4% YoY
Jubilant Agri and Consumer Products Board Meeting Date
Jubilant Agri and Consumer Products intimated a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The letter is a prior intimation under Regulation 29.
Jubilant Agri and Consumer Products Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This is a routine compliance submission.
Jubilant Agri and Consumer Products Merger & Restructuring
Jubilant Agri and Consumer Products Limited informs the Exchange that the NCLT passed an order regarding the second motion petition for its Scheme of Arrangement.
Jubilant Agri and Consumer Products Credit Rating
Jubilant Agri and Consumer Products Limited received a reaffirmation of its credit ratings from CARE Ratings Limited for its existing bank facilities.
Other employee stock options announcements
All →Sai Life Science Employee Stock Options
Sai Life Sciences allotted 108,005 ESOP equity shares, taking paid-up capital to Rs.21.26 Crore. No stated consideration means no event value.
Billionbrains Garage Ventures Employee Stock Options
Billionbrains Garage Ventures granted 21,63,086 stock options to eligible employees under its 2024 ESOP scheme. Each option carries an exercise price of Rs. 2 per share.
Healthcare Global Enterprises Employee Stock Options
HealthCare Global granted 70,000 employee stock options at a Rs 495 exercise price under its 2026 ESOS. Options vest within one to seven years.
- Execution
- Vesting 1 to 7 years from grant; exercisable for up to 10 years from grant
Zensar Technologies Employee Stock Options
Zensar Technologies allotted 31,440 equity shares to employees on exercise of ESOPs. Paid-up share capital rose to ₹45.55 crore across 22.78 crore shares.
IIFL Finance Employee Stock Options
IIFL Finance allotted 1,97,523 equity shares to eligible employees on exercise of ESOPs, approved by the NRC on 5 November 2026. No cash consideration per share is stated in the filing.
Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.